Ignite Creation Date:
2024-05-05 @ 5:01 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00367757
Status:
COMPLETED
Last Update Posted:
2019-01-30
First Post:
2006-08-22
Brief Title:
STAR-AFSubstrate Versus Trigger Ablation for Reduction of Atrial Fibrillation Trial
Sponsor:
Abbott Medical Devices
Organization:
Abbott Medical Devices
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Atrial Fibrillation |
Keywords:
| Name | View |
|---|---|
| paroxysmal atrial fibrillation | View |
| persistent atrial fibrillation | View |
| high burden of atrial fibrillation | View |
| atrial fibrillation ablation | View |
| Pulmonary vein isolation | View |
| AF trigger | View |
| complex fractionated electrograms | View |
| CFE | View |
| CFAE | View |
| complex fractionated atrial electrograms | View |
| refractory antiarrhythmic medication | View |
| PVAI | View |
| Ensite NavX | View |
| NavX | View |
| CoolPath catheter | View |
| irrigated ablation catheter | View |
| high burden of paroxysmal or persistent atrial fibrillation | View |
| candidates for AF ablation | View |
| symptomatic AF | View |
| AF is refractory to at least one antiarrhythmic medication | View |